Iris Biotechnologies Inc (IRSB) financial statements (2021 and earlier)

Company profile

Business Address 5201 GREAT AMERICA PARKWAY
SANTA CLARA, CA 95054
State of Incorp. NY
Fiscal Year End December 31
SIC 3841 - Surgical and Medical Instruments and Apparatus (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

12/31/2015
12/31/2014
12/31/2013
12/31/2012
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments20323191
Cash and cash equivalents20323191
Prepaid expense40 
Other undisclosed current assets (0) 15
Total current assets:233231916
Noncurrent Assets
Property, plant and equipment30949
Total noncurrent assets:30949
TOTAL ASSETS:533322325
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:12423714697
Accounts payable 23714697
Other undisclosed accounts payable and accrued liabilities124   
Debt 5(45) 
Derivative instruments and hedges, liabilities169   
Due to related parties1750  
Other undisclosed current liabilities  90 
Total current liabilities:46924219197
Noncurrent Liabilities
Long-term debt and lease obligation26261647
Long-term debt, excluding current maturities26261647
Total noncurrent liabilities:26261647
Total liabilities:495268207144
Stockholders' equity
Stockholders' equity attributable to parent, including:(441)64(184)(119)
Common stock8,8518,3567,1236,791
Common stock, share subscribed but unissued, subscriptions receivable(128)(128)(128)(128)
Additional paid in capital2,8782,7052,4992,410
Accumulated deficit(12,042)(10,869)  
Other undisclosed stockholders' equity attributable to parent  (9,677)(9,192)
Total stockholders' equity:(441)64(184)(119)
TOTAL LIABILITIES AND EQUITY:533322325

Income statement (P&L) ($ in thousands)

12/31/2015
12/31/2014
12/31/2013
12/31/2012
Operating expenses(1,058)(1,190)(481)(584)
Other undisclosed operating income  3,3243,279
Operating income (loss):(1,058)(1,190)2,8432,694
Nonoperating expense
(Other Nonoperating expense)
(115)   
Net income (loss):(1,173)(1,190)2,8432,694
Other undisclosed net loss attributable to parent (2)(3,329)(3,280)
Net loss available to common stockholders, diluted:(1,173)(1,192)(486)(586)

Comprehensive Income ($ in thousands)

12/31/2015
12/31/2014
12/31/2013
12/31/2012
Net income (loss):(1,173)(1,190)2,8432,694
Other comprehensive loss(56)   
Comprehensive income (loss), net of tax, attributable to parent:(1,229)(1,190)2,8432,694

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: